Crestwood Advisors Group LLC Organon & Co. Transaction History

Crestwood Advisors Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 07, 2022	BUY	$31.66 - $38.9 $188,630 - $231,766	5,958 New	5,958 $201,000
Q1 2022 Apr 12, 2022	SELL	$30.45 - $39.36 $418,504 - $540,963	-13,744 Closed	0 $0
Q4 2021 Feb 15, 2022	SELL	$28.67 - $37.13 $44,266 - $57,328	-1,544 Reduced 10.1%	13,744 $419,000
Q3 2021 Nov 03, 2021	SELL	$28.63 - $35.64 $170,520 - $212,271	-5,956 Reduced 28.04%	15,288 $501,000
Q2 2021 Aug 13, 2021	BUY	$28.45 - $38.0 $604,391 - $807,272	21,244 New	21,244 $643,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

Stay updated on Crestwood Advisors Group LLC with notifications on news.